Genta, Inc (fka GNTAQ)

[pigsGETslaughtered21]

"Last month, Genta announced presentation of results from its Phase IIb clinical trial using tesetaxel as initial, single-agent chemotherapy in women with advanced breast cancer.

Dr. Loretta M. Itri, president of Pharmaceutical Development and chief medical officer at Genta, said last month that the data confirm significant activity for tesetaxel as initial chemotherapy for women with advanced, HER2-negative, breast cancer. Itri said that based on aggregate data from the multicenter Phase II clinical trials, the company will be conferring with FDA to identify potential registration strategies for tesetaxel in breast cancer."